Compare Consolidated Edison, Inc. (ED) vs GE HealthCare Technologies Inc. Common Stock (GEHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Consolidated Edison, Inc. vs GE HealthCare Technologies Inc. Common Stock — how do they compare? Consolidated Edison, Inc. trades at $109.55 (market cap $39.87B), while GE HealthCare Technologies Inc. Common Stock trades at $68.66 (market cap $31.07B). The key difference: Consolidated Edison, Inc. is the larger of the two by market cap, and Consolidated Edison, Inc. pays the higher dividend (3.26%). Which is the better fit depends on your goals.
| ED | GEHC | |
|---|---|---|
Market Cap | $39.87B | $31.07B |
Volume | 1,579,122 | 3,443,020 |
Sector | Utilities | Health |
52-Week High | $115.46 | $88.16 |
52-Week Low | $95.37 | $59.48 |
Typical Hold Time | 76 Days | — |
Enterprise Value | $66.72B | $39.53B |
Dividend Yield | 3.26% | 0.23% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Consolidated Edison (ED) trades at $109.60, up 2.24% with a bullish technical signal. The stock shows strong fundamentals with $16.92B revenue, 12.53% net margin, and consistent dividend payments. Recent earnings show mixed results with Q2 beat but Q1 miss. The company maintains solid cash flow generation of $4.8B from operations in 2025 while investing heavily in infrastructure.
ED presents a stable utility investment with moderate growth and reliable dividends, though analyst consensus leans heavily toward Hold (63%). Key risks include regulatory pressures and capital-intensive infrastructure demands. The current price sits above the $105.56 consensus target, suggesting limited near-term upside despite positive economic impact from New York operations.
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Consolidated Edison, Inc.
Con Ed is a holding company for Consolidated Edison of New York, or CECONY, and Orange & Rockland, or O&R. These utilities provide steam, natural gas, and electricity to customers in southeastern New York—including New York City—and small parts of New Jersey. The two utilities will generate nearly all of Con Ed's earnings once it closes the sale of its clean energy business to RWE. Con Ed's clean energy business owns the second-largest portfolio of utility-scale solar projects in the U.S. Following the sale, Con Ed's only non-utility earnings will come from investments in gas and electric transmission.
Read more on ED →About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →
